GA NCORP

Treatment Sites

Northeast Georgia Medical Center - Gainesville

Nationally Ranked Cancer Services NGMC cares for more than 2,800 new cancer patients each year. That means our community has access to expert physicians, advanced cancer fighting technologies and some of the nation’s leading clinical trials. NGMC's Cancer Services are accredited with commendation by the American College of Surgeons Commission on Cancer (CoC)at the highest level of accreditation possible. NGMC is the only program in Georgia – and one of only 24 programs in the nation – to receive the 2018 Outstanding Achievement Award by the CoC.

Treatment Sites


Primary Location

NGMC-Gainesville
Wisteria Building Suite 420
200 South Enota
Gainesville, GA 30501
770-219-9010 (p)
770-219-7580 (f)
www.nghs.com

driving directions


Medical Plaza 1 Braselton

1515 River Place
Braselton, 30517
770-848-6070 (p)
www.nghs.com

driving directions


Toccoa Cancer Center

1640 Falls Rd.
Toccoa, 30577
706-297-7023 (p)
www.nghs.com

driving directions

Clinical Trials

Crizotinib in Treating Patients with Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Cancer Type: Lung Cancer
Study Coordinator: Trena Davis BSN, RN, CRCC - 770-219-8822


Eflornithine and/or Sulindac in Preventing Recurrence of High-Risk Adenomas and Second Primary Disease in Patients with Stage 0-III Colon or Rectal Cancer
Cancer Type: Colon/Rectal Cancer, Unknown Primary
Study Coordinator: Trena Davis BSN, RN, CRCC - 770-219-8822


Genetic Testing in Screening Patients with Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
Cancer Type: Lung Cancer
Study Coordinator: Trena Davis BSN, RN, CRCC - 770-219-8822


Lymph Node Dissection and Radiation Therapy in Treating Patients with Breast Cancer Previously Treated with Chemotherapy and Surgery
Cancer Type: Breast Cancer, Unknown Primary
Study Coordinator: Trena Davis BSN, RN, CRCC - 770-219-8822


Radiation Therapy with or without Chemotherapy in Patients with Stage I-IIA Cervical Cancer Who Previously Underwent Surgery
Cancer Type: Cervical Cancer

Targeted Therapy Directed by Genetic Testing in Treating Patients with Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Cancer Type: Bladder Cancer, Brain & Spinal Cord Tumor, Breast Cancer, Cervical Cancer, Colon/Rectal Cancer, Esophogeal Cancer, Head and Neck Cancer, Kidney Cancer, Liver Cancer / Hepatoblastoma, Lung Cancer, Lymphoma, Melanoma, Multiple Myeloma, Ovarian Cancer, Pancreatic Cancer, Plasma cell neoplasm, Prostate Cancer , Skin Cancer (Non-Melanoma), Stomach/ Gastric Cancer, Thyroid Cancer, Unknown Primary, Uterine Cancer
Study Coordinator: Trena Davis BSN, RN, CRCC - 770-219-8822